Publications

Implications for sequencing of biologic therapy and choice of second anti-TNF in patients with inflammatory bowel disease: results from the IMmunogenicity to Second Anti-TNF Therapy (IMSAT) therapeutic drug monitoring study
29 Aug 2022 in Alimentary Pharmacology and Therapeutics, vol. 56, pp. 1250-1263
DOI: https://doi.org/10.1111/apt.v56.8
Research output: Contribution to Journal › Article (Published)

Patterns of emergency admission for IBD patients over the last 10 years in Lothian, Scotland: A retrospective prevalent cohort analysis
17 Mar 2022 in Alimentary Pharmacology and Therapeutics
DOI: https://doi.org/10.1111/apt.16867
Research output: Contribution to Journal › Article (E-pub ahead of print)

COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): a multicentre, prospective, case-control study
3 Feb 2022 in The Lancet Gastroenterology & Hepatology
DOI: https://doi.org/10.1016/S2468-1253(22)00005-X
Research output: Contribution to Journal › Article (E-pub ahead of print)

Disease Monitoring in Inflammatory Bowel Disease: Evolving Principles and Possibilities
29 Jan 2022 in Gastroenterology
DOI: https://doi.org/10.1016/S2468-1253(22)00005-X
Research output: Contribution to Journal › Article (E-pub ahead of print)

Real-world experience with tofacitinib in ulcerative colitis - a systematic review and meta-analysis
23 Dec 2021 in Therapeutic Advances in Gastroenterology
DOI: https://doi.org/10.1177/17562848211064004
Research output: Contribution to Journal › Article (Published)

View all 77 publications on Research Explorer

Data last updated: 14/12/2022 at 10:55